NCT04871945已完成不适用
Evaluation of Protective Antibody Production After COVID-19 Vaccination Among Patients Under Hemodialysis
Hanyang University Seoul Hospital1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2021年4月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 31
- 试验地点
- 1
- 主要终点
- The change in the level of neutralizing antibody against SARS-CoV-2
研究概览
简要总结
The aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis. To this end, the level of neutralizing antibody of patients under hemodialysis is compared to that of healthy population.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •The person who is vaccinated with ChAdOx1 (COVID-19 vaccine)
- •The person who agrees with the protocol of the study
排除标准
- •Age < 18 years
- •Pregnants
- •Experience of COVID-19 infection
结局指标
主要结局
The change in the level of neutralizing antibody against SARS-CoV-2
时间窗: Day 0, 14, 28, 56, 91, 120
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Effect of SARS-CoV-2 Vaccination in Liver Transplant RecipientsSARS-CoV-2 VaccinationLiver TransplantationNCT05490342University of Rome Tor Vergata61
Unknown
4 期
A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19COVID-19 VaccineNCT05097053Taoyuan General Hospital200
撤回
不适用
Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised PatientsHIV SeropositivityVaccination ReactionCovid19ImmunodeficiencyNCT05672654University Hospital, Ghent
Unknown
不适用
Immunogenicity Against SARS-CoV-2 in COVID-19 Close ContactsCovid19Vaccine ReactionNCT05094635University of Medicine and Pharmacy at Ho Chi Minh City772
撤回
2 期
Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to VaccinationCovid19NCT04930770Maria Joyera Rodríguez